Physician profile
Cheryl L Sizer
NPI 1245899806
$1,099.28
in general payments reported to CMS, 2019-2025
9 companies · $94.71 in 2025
The $94.71 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $109 · 2022: $214 · 2023: $601 · 2024: $80.61 · 2025: $94.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715 · Education: $61.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.41 |
| Education | $61.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $298.56 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Abbvie INC. | $206.84 | 2021-2022 | |
| Lilly USA, LLC | $161.38 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $89.63 | 2023 | |
| Exelixis INC. | $87.32 | 2023 | Cabometyx |
| Merck Sharp & Dohme LLC | $80.61 | 2024 | Lynparza |
| Kci USA, INC. | $69.60 | 2023 | Activ.A.C., Promogran Prisma |
| Acella Pharmaceuticals, LLC | $66.59 | 2023 | NP Thyroid 60 |
| Smith+Nephew, INC. | $38.75 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Sizer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.